Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous SHED intravenous administration in children with chronic cerebral palsy
jRCTb040230042Active, not recruiting
- Sponsor
- S-Quatre
- Start
- Oct 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial in cerebral palsy (CP) and hypoxic-ischemic encephalopathy (HIE), sponsored by S-Quatre. Primary endpoint: Adverse events. Started Oct 2023; status: active, not recruiting.
02
Conditions
cerebral palsy (CP)hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on jRCTb040230042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb040230042.